Tag: RDIF
RDIF & Morepen Laboratories to soon begin production of Sputnik V...
RDIF and Morepen Laboratories signed a cooperation agreement in June 2021 and are actively implementing the technology transfer.......................
Panacea Biotec to produce 100 million doses of Sputnik V annually
The first batch of Russia's COVID-19 vaccine produced at Panacea Biotec’s facilities in Baddi will be shipped to the Gamaleya Center for quality control.................
Panacea Biotec to produce 100 million doses of Sputnik V vaccine
The move is expected to facilitate the global supply of Sputnik V vaccine to international partners of the Russian Direct Investment Fund (RDIF).................................
RDIF & Virchow Biotech partner for production of Sputnik V vaccine...
Virchow Biotech capacities will help facilitate the global supply of Sputnik V to international partners of RDIF.......................
RDIF & Stelis Biopharma partner to supply 200 million doses of...
Sputnik V is a two-dose vaccine that uses two different human adenoviral vectors in the course of vaccination......................
First batch of Sputnik V vaccine delivered to Mexico
Sputnik V is approved for use in more than 30 countries making the vaccine one of the world's top three coronavirus vaccines in terms of the number of approvals issued by regulatory authorities.....................
COVID-19 Vaccine Cocktail: AstraZeneca to use components of Russia’s Sputnik V...
AstraZeneca accepted the proposal by RDIF and the Gamaleya Center to use one of the two vectors of the Sputnik V vaccine in additional clinical trials of its own vaccine, which will commence before the end of this year...................
Dr Reddy’s & RDIF commence clinical trials for Sputnik V vaccine...
The clinical trials are being conducted by JSS Medical Research as a clinical research partner...................
RDIF & Hetero agree to produce 100 million doses of the...
Currently, Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries, as well as Phase II-III in India..........................
Russia’s Sputnik V vaccine shows 95% efficacy after 42 days, one...
Currently, 40,000 volunteers are taking part in Phase III double-blind, randomized, placebo-controlled clinical post-registration study of the Sputnik V vaccine in Russia. The vaccine will be available in the lyophilized (dry) which is stored at a temperature of +2 to +8 degrees celsius...................